Personalized medicine, says this article in T he Scientist , could breathe new life into failed drug candidates . “If Merck could have known in advance who would have cardiovascular problems from Vioxx, they may not have had to withdraw it from the market,” Personalized Medicine Coalition’s Edward Abrahams says.
Merck's defense of Vioxx is beginning to look ugly - and costing the company millions in legal fees and punitive damages. But make no mistake, the company's fight-every-case strategy is still its only rational option.
Jurors rule for Merck in N.J. Vioxx case
Merck & Co. won a crucial legal victory on Thursday, when jurors decided that the drugmaker's Vioxx painkiller, now the subject of at least 16,000 product liability lawsuits, did not cause a 68-year-old woman's heart attack.
The ripple effect of Vioxx is moving from Capitol Hill and into local courtrooms. Merck voluntarily recalled its popular pain reliever earlier this year after evidence linked the drug to heart attacks and strokes. The onslaught of television ads from attorneys looking to hear your Vioxx story is here to stay for now. One local lawyer says there is a market for legal claims against Merck. Michael Maloof is one of thousands who... more...
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved